MIRM logo

Mirum Pharmaceuticals (MIRM)

Profile

Full Name

Mirum Pharmaceuticals, Inc.

Ticker Symbol

MIRM

Exchange

NASDAQ

Country

United States

IPO

July 18, 2019

Indexes

Not included

Employees

322

Key Details

Price

$39.12(-5.67%)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$336.89M(+80.76% YoY)

Annual EPS

-$1.85(+53.75% YoY)

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 28, 25 HC Wainwright & Co.
Buy
Feb 27, 25 Baird
Outperform
Feb 24, 25 Citizens Capital Markets
Market Outperform
Nov 13, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Citigroup
Buy
Nov 13, 24 Baird
Outperform
Oct 17, 24 Leerink Partners
Outperform
Oct 11, 24 HC Wainwright & Co.
Buy
Aug 8, 24 Evercore ISI Group
Outperform
Aug 8, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

  • What is the ticker symbol for Mirum Pharmaceuticals?
  • Does Mirum Pharmaceuticals pay dividends?
  • What sector is Mirum Pharmaceuticals in?
  • What industry is Mirum Pharmaceuticals in?
  • What country is Mirum Pharmaceuticals based in?
  • When did Mirum Pharmaceuticals go public?
  • Is Mirum Pharmaceuticals in the S&P 500?
  • Is Mirum Pharmaceuticals in the NASDAQ 100?
  • Is Mirum Pharmaceuticals in the Dow Jones?
  • When was Mirum Pharmaceuticals's last earnings report?
  • When does Mirum Pharmaceuticals report earnings?
  • Should I buy Mirum Pharmaceuticals stock now?

What is the ticker symbol for Mirum Pharmaceuticals?

The ticker symbol for Mirum Pharmaceuticals is NASDAQ:MIRM

Does Mirum Pharmaceuticals pay dividends?

No, Mirum Pharmaceuticals does not pay dividends

What sector is Mirum Pharmaceuticals in?

Mirum Pharmaceuticals is in the Healthcare sector

What industry is Mirum Pharmaceuticals in?

Mirum Pharmaceuticals is in the Biotechnology industry

What country is Mirum Pharmaceuticals based in?

Mirum Pharmaceuticals is headquartered in United States

When did Mirum Pharmaceuticals go public?

Mirum Pharmaceuticals's initial public offering (IPO) was on July 18, 2019

Is Mirum Pharmaceuticals in the S&P 500?

No, Mirum Pharmaceuticals is not included in the S&P 500 index

Is Mirum Pharmaceuticals in the NASDAQ 100?

No, Mirum Pharmaceuticals is not included in the NASDAQ 100 index

Is Mirum Pharmaceuticals in the Dow Jones?

No, Mirum Pharmaceuticals is not included in the Dow Jones index

When was Mirum Pharmaceuticals's last earnings report?

Mirum Pharmaceuticals's most recent earnings report was on Feb 26, 2025

When does Mirum Pharmaceuticals report earnings?

The next expected earnings date for Mirum Pharmaceuticals is May 8, 2025

Should I buy Mirum Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page